Detalhe da pesquisa
1.
Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland.
Future Oncol
; 20(8): 459-470, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529943
2.
A UK cost-effectiveness analysis of trifluridine/tipiracil for heavily pretreated metastatic gastroesophageal cancers.
Future Oncol
; 19(9): 643-650, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115022
3.
Predicting Survival for Chimeric Antigen Receptor T-Cell Therapy: A Validation of Survival Models Using Follow-Up Data From ZUMA-1.
Value Health
; 25(6): 1010-1017, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667774
4.
"Stick or Twist?" Negotiating Price and Data in an Era of Conditional Approval.
Value Health
; 23(2): 191-199, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32113624
5.
Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection.
BMC Med Res Methodol
; 20(1): 103, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32375680
6.
Real-world evidence use in assessments of cancer drugs by NICE.
Int J Technol Assess Health Care
; : 1-7, 2020 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646531
7.
Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study.
Value Health
; 22(3): 276-283, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30832965
8.
Don't keep me waiting: estimating the lifetime impact of reduced vein-to-vein time for CAR-T treated patients with LBCL.
Blood Adv
; 2024 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662645
9.
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.
Pharmacoeconomics
; 42(7): 737-749, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676871
10.
An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology.
Appl Health Econ Health Policy
; 21(3): 385-394, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849703
11.
De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis-Modeling Approach and Validation.
Pharmacoeconomics
; 41(12): 1629-1639, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505423
12.
A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment.
Med Decis Making
; 43(5): 610-620, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125724
13.
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time.
Pharmacoeconomics
; 40(3): 249-256, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34866171
14.
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches.
Appl Health Econ Health Policy
; 19(3): 389-401, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314001
15.
Cost-Effectiveness Analysis of rFVIIIFc Versus Contemporary rFVIII Treatments for Patients with Severe Hemophilia A Without Inhibitors in the United States.
Pharmacoecon Open
; 5(4): 625-633, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34268704
16.
An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA).
Open Access Rheumatol
; 13: 257-266, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531691
17.
A comparison of partitioned survival analysis and state transition multi-state modelling approaches using a case study in oncology.
J Med Econ
; 23(10): 1176-1185, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673128
18.
Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data.
Pharmacoecon Open
; 4(1): 133-142, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31280415
19.
Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal.
Pharmacoeconomics
; 38(12): 1309-1318, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32875526
20.
A Review of Recent Decision-Analytic Models Used to Evaluate the Economic Value of Cancer Treatments.
Appl Health Econ Health Policy
; 17(6): 771-780, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31485867